The Business Research Company’s Erythropoietin (EPO) Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Erythropoietin (EPO) Global Market Report 2023 evaluates erythropoietin (EPO) market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
The global erythropoietin market grew from $13.94 billion in 2022 to $15.52 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The erythropoietin market is expected to grow from $24.2 billion in 2027 at a CAGR of 11.7%.
The erythropoietin (EPO) market segments in the report are:
Erythropoietin (EPO) Market By Product:
- Other Products
Erythropoietin (EPO) Market By Application
- Renal diseases
- Other Applications
Erythropoietin (EPO) Market By Drug Class
Top Key players
- Amgen Inc.
- Johnson & Johnson
- Roche Group
- Pfizer Inc.
North America was the largest region in the erythropoietin (EPO) market in 2022.
Get More Information On The Erythropoietin (EPO) Market Report:
The table of contents in TBRC’s erythropoietin (EPO) market report includes:
- Executive Summary
- Erythropoietin (EPO) Market Characteristics
- Erythropoietin (EPO) Market Trends And Strategies
- Erythropoietin (EPO) Market – Macro Economic Scenario
- Erythropoietin (EPO) Market Size And Growth.
- Erythropoietin (EPO) Pipeline Analysis
- Key Mergers And Acquisitions In The Erythropoietin (EPO) Market
- Erythropoietin (EPO) Market Future Outlook and Potential Analysis
List Of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Erythropoietin (EPO) Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46: Amgen Inc. Financial Performance
Table 47: Johnson & Johnson Financial Performance
Table 48: Roche Group Financial Performance
Table 49: Pfizer Inc. Financial Performance
Table 50: Novartis Financial Performance
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model